J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...
Examining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on vaccines, autism, ...
Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at CBER.
On Thursday, researchers published in Science the results of a study that tested an OpenAI model on diagnostic and clinical ...
WASHINGTON — The Trump administration has dropped its nomination of Casey Means to be the next surgeon general, opting ...
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of ...
Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The Readout ...
Elevance Health is blocking the deposition of Peter Haytaian, an outgoing executive who previously oversaw the health insurer ...
The likelihood of snagging NIH grants has plunged to historic lows, forcing academic researchers to resort to a variety of ...
ACA membership is tumbling after Congress failed to extend extra subsidies that helped people afford the coverage.
A preclinical next-gen obesity drug is stacking five mechanisms (in mice). Also, the NIH funding climate is rougher than ever ...
FDA's plan to use AI to speed up trials, Hinge's new migraine device, and boosting cancer screening with texts.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results